U.S. markets close in 40 minutes

Cardlytics, Inc. (CDLX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
124.81-6.13 (-4.68%)
As of 3:19PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close130.94
Open130.72
Bid124.78 x 800
Ask125.32 x 900
Day's Range123.01 - 130.79
52 Week Range55.89 - 161.47
Volume136,766
Avg. Volume376,523
Market Cap4.103B
Beta (5Y Monthly)2.60
PE Ratio (TTM)N/A
EPS (TTM)-2.40
Earnings DateAug 03, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est143.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Cardlytics Announces Timing of Its Second Quarter 2021 Financial Results Conference Call and Webcast
    GlobeNewswire

    Cardlytics Announces Timing of Its Second Quarter 2021 Financial Results Conference Call and Webcast

    ATLANTA, July 20, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), one of the largest digital advertising platforms, today announced that its second quarter ended June 30, 2021 financial results will be released on Tuesday, August 3, 2021, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results. A live audio webcast of the event will be available on the Cardlytics Investor Relations website at htt

  • Is Cardlytics (NASDAQ:CDLX) Using Debt In A Risky Way?
    Simply Wall St.

    Is Cardlytics (NASDAQ:CDLX) Using Debt In A Risky Way?

    Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

  • Hedge Funds Can’t Buy Enough Of Cardlytics, Inc. (CDLX)
    Insider Monkey

    Hedge Funds Can’t Buy Enough Of Cardlytics, Inc. (CDLX)

    In this article we are going to use hedge fund sentiment as a tool and determine whether Cardlytics, Inc. (NASDAQ:CDLX) is a good investment right now. We like to analyze hedge fund sentiment before conducting days of in-depth research. We do so because hedge funds and other elite investors have numerous Ivy League graduates, expert […]